Concord Biotech Approves 1:1 Bonus Issue; Authorised Share Capital to Double
September 23, 2026
Concord Biotech Limited (NSE: CONCORDBIO, BSE: 543960) has approved a 1:1 bonus share issue, subject to shareholder approval, according to the outcome of its Board meeting held on September 23,…